Vasculitis & polymyalgia rheumatica

Biomarker trajectories and risk of relapse in giant cell arteritis: a multicenter study

Semin Arthritis RheumPublished multicenter retrospective study

Authors' conclusion

In our GCA cohort, relapse risk was associated with cranial manifestations and aortic uptake on PET-CT at diagnosis. PF normalization at 1 month was identified as an early marker of a lower relapse risk, although this biomarker requires external validation. CRP and PF trajectories identified distinct phenotypes associated with different relapse risks, supporting further evaluation of longitudinal biomarker-guided follow-up.

Study context

Population
Patients diagnosed with giant cell arteritis (GCA) between 2000 and 2023 fulfilling GiACTA inclusion criteriapatients diagnosed with GCA, CRP and plasma fibrinogen (PF) collected until relapse or up to 2 years in a subset diagnosed from 2017 to 2022 · Subset diagnosed from 2017 to 2022 with longitudinal CRP and PF 135
Participants
465 patients
Exposure
Associations between biomarker dynamics and relapse
Outcome
≥ 1 relapse
Follow-up
Within 5 years
Methodological detailsjoint modeling
  • Joint modeling

Main finding

As reported in the abstract

Patients with ≥ 1 relapse

34.2%

Observational data: associations, not effects.

Further findings

Relapse, by PF normalization at 1 month · over 2 years

HR (95% CI)P value
PF normalization at 1 month0.14 (0.07–0.28)P < 0.001
  • Relapse, by PF normalization at 1 month: lower relapse risk with PF normalization at 1 month; comparator not stated

Baseline characteristics associated with relapse · At diagnosis

Headache, jaw claudication and aortic FDG uptake on PET-CT were associated with higher relapse risk

Discrimination of PF at month 1 for relapse

AUC
0.82 (bootstrap 95% CI 0.69-0.91)
Exploratory ROC-derived cut-off
3.77 g/L (bootstrap 95%CI, 3.45-3.97)
Sensitivity at cut-off
71.8%
Specificity at cut-off
90.0%

Individual trajectories of CRP and PF

Trajectories were heterogeneous and identified distinct phenotypes associated with different relapse risks

Original publication

Biomarker trajectories and risk of relapse in giant cell arteritis: a multicenter study. Semin Arthritis Rheum. Published 4 November 2026. doi:10.1016/j.semarthrit.2026.153103

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.